Ledger.Open graph →
SEC Form D · filed May 12, 2011

SpringLeaf Therapeutics, Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Industry
Pharmaceuticals
Location
Boston, MA
Type

People & firms on this filing (18)

Michael Cima · Boston, MADirectorGaren Bohlin · Boston, MADirectorGlenn Larsen · Boston, MAExecMichael Greeley · Boston, MADirectorFrank Bobe · Boston, MAExec · DirectorJeffrey Mccarthy · Boston, MADirectorYet-Ming Chiang · Boston, MADirectorKurt Graves · Boston, MADirectorBrian Gallagher · Dublin, IrelandDirectorRobin K. Bacon · Petaluma, CAExec · DirectorMatthew G. Duffy · Petaluma, CADirectorGarrett Bernstein · Petaluma, CADirectorElizabeth A. Pearce · Petaluma, CADirectorLarry L. Faydo · San Diego, CADirectorJack Vanderknyff · Oceanside, CADirectorDaniel Holland · Hingham, MADirectorPatrick Rivelli · Marco Island, FLExecBrian Gallagher · Simsbury, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗